Of the three important quantitative aspects of iodine metabolism-thyroidal iodide accumulation, release of organically bound iodine from the thyroid and metabolism of organic iodine in the body tissues, only the first has been measured adequately in man (1). The purpose of the present report is to outline methods for the quantitative evaluation of: 1) The organic iodine pools of the body; 2) the rate of thyroidal secretion of organically bound iodine; 3) the metabolic degradation and fecal excretion of organically bound iodine ;1 and 4) exogenous and endogenous iodine balance.
Of the three important quantitative aspects of iodine metabolism-thyroidal iodide accumulation, release of organically bound iodine from the thyroid and metabolism of organic iodine in the body tissues, only the first has been measured adequately in man (1) . The purpose of the present report is to outline methods for the quantitative evaluation of: 1) The organic iodine pools of the body; 2) the rate of thyroidal secretion of organically bound iodine; 3) the metabolic degradation and fecal excretion of organically bound iodine ;1 and 4) exogenous and endogenous iodine balance.
The technical methods employed and the schematic model on which the analyses are based are common to all the determinations and are presented first. The specific analyses and results obtained for the various phases of iodine metabolism are then considered in separate sections. An attempt has been made to follow a similar order of presentation in each of these sections. The theoretical basis for the methods employed in the measurement of each aspect of iodine metabolism is followed by a sample calculation from the observed data in one of the subjects, R. D. Reference is then usually made to the results of the measurements, and the section is concluded with an analysis of the validity of the determinations and the sources of error.
TECHNICAL METHODS
Subjects were hospitalized euthyroid and hyperthyroid patients. In all cases the diagnoses were confirmed by several observers and considered established without refer- ' This process has occasionally been referred to as hormonal iodine utilization. Since it is questionable whether the organic iodine released by the thyroid represents homogeneous hormonally active substance or whether all organic iodine which undergoes degradation is utilized in any strict metabolic sense, it seems preferable to use the more general term, organic iodine degradation, in place of hormonal iodine utilization.
ence to the results obtained in the radioactive iodine tests. One hundred to two hundred pc of I'll were administered intravenously, as carrier-free sodium iodide. At intervals thereafter, radioactivity in the thyroid, blood and urinary and fecal excretions was assayed. A bismuth-walled Geiger tube was used for the thyroid assays according to methods previously described (2) and a well-type scintillation counter was employed for assays of radioactivity in blood and excreta. Five ml. samples of plasma or packed erythrocytes were counted with a sensitivity of 1.03 X 106 counts per minute per pc 1181 above a background of about 200 counts per minute. Two hundred ml. samples of urine were counted in a constant geometrical relationship to the scintillation crystal. with a sensitivity of 8.3 X 104 counts per minute per pc I'n above a background of about 300 counts per minute. Twenty-four hour stool collections were made up to 300 ml. volumes with water, homogenized in an Oster mixer, and counted in a similar manner with a sensitivity of 3.7 X 104 counts per minute per uc I'l. PBI117 in plasma was determined by the method of Barker, Humphrey, and Soley (3).2 PB1131 and iodide"' in plasma were determined from assays of plasma and packed red cells utilizing the plasma: erythrocyte ratio of iodide"' (usually 1.6 to 1.8) for each subject and the observation that PB1131 is not detectable in packed cells when allowance is made for trapped plasma. In many instances 10 per cent cold trichloracetic acid was added to the plasma and precipitate and filtrate were separately assayed. However, since it was observed that trichloracetic acid frequently precipitated significant quantities of 1131 as iodide added to plasma, the method described above was considered more reliable for the quantitative separation of iodide and PBI. Complete urine and stool collections were made during the periods of observation in most of the cases. After there appeared to be equilibration of the 1131 in the exchangeable organic iodine pool, 1-methyl-2 mercaptoimidazole (tapazole) was administered in doses of 25 to 30 mgm. every six hours, which are sufficient to inhibit thyroidal iodide binding almost completely (4) .
In another type of experiment, the concentration of PBI'm in the plasma was followed for about 10 days in three subjects who received labeled plasma from a donor treated with 8.5 mc. I131 for Graves' disease. ' We are indebted to Dr. Solomon Silver and to Mr. Herbert Lew in the laboratory of Dr. Bruno Volk for these determinations.
SOLOMON A. BERSON AND ROSALYN S. YALOW SCHEMATIC MODEL
For the purpose of orientation, the major pathways of iodine transport are summarized briefly with reference to the schematic model shown in Figure 1 . Intravenously administered radioiodide is distributed rapidly among the iodide pools of blood, tissue fluids, and thyroid gland. Clearance of the total iodide pool is effected by binding in the thyroid and excretion in the urine. Organically bound 1131 released from the thyroid into the plasma and tissue fluids is subject to metabolic degradation, the principal end product being iodide which then repeats the cycle. A small amount of non-protein bound organic iodine is also excreted by the kidneys (5) but usually comprises only a small fraction of the total urinary iodine. There is also a loss of organic iodine in the stool which may represent only a fraction of the total iodine transfer through the 
GLAND
Following peak thyroidal uptake and renal excretion of the administered iodide1"', the radioactive iodine remaining in the body is almost entirely in an organic form undergoing distribution between thyroidal and extrathyroidal organic iodine pools. See text for discussion. enterohepatic circulation (6) . Since virtually the entire administered dose of I'3l was accounted for in the urinary and stool excretions in our cases followed for prolonged periods, no other major excretory pathway need be considered. The radioiodine retained in the body at any time (I") is then determined by subtracting the cumulative urinary and fecal excretions from the dose administered.
In normal and hyperthyroid subjects, the total iodine present in the enterohepatic circulation and in the iodide fraction of the thyroid and extrathyroidal tissues at any time represents only a small part of the total iodine content of the body. Therefore, following initial clearance of the administered radioiodide, the major portion of the radioiodine in the body may be considered to be undergoing distribution between two compartments, the thyroidal and extrathyroidal organic iodine pools (Figure 2) These determinations are based on the assumption that when a tracer substance has mixed uniformly in all its compartments of distribution, the specific activity is the same in all these compartments and, in the absence of turnover, remains constant. In the present section radioactivity is treated only in terms of the I'll remaining in the body (I"') thus obviating the necessity for consideration of turnover of the pool with newly ingested iodine.
A. The total exchangeable organic iodine pool Following peak uptake by the thyroid, the curves of thyroidal radioactivity and plasma concentration of PBI118, plotted as fractions of I13' vs. time, each approach an horizontal asymptote (Figures 3a, 4 as 20,000 micrograms (Table I ). The pool sizes were generally much reduced in those subjects who had been treated previously with tapazole, radioiodine or surgery.
Inactive pools not entered by the administered radioiodine cannot, of course, be detected under these circumstances. However, the maintenance of a constant specific activity in the plasma for several weeks ( Figure 5 ), during anti-thyroid therapy with tapazole, when thyroidal and plasma radioactivity may fall to 50 per cent or less of the control values, indicates that such unexchangeable pools which might exist are not readily mobilized, even in the presence of moderate depletion of iodine stores.
In one euthyroid subject (G. M., Figure 4 ), a plateau in the plasma concentration (I13') curve was not obtained even after several weeks. The size of his exchangeable organic iodine pool as given in Table I is therefore overestimated since it was calculated from the specific activity on the last day of observations, instead of the higher specific activity which would have been obtained at equilibrium.
B. Thyroidal and extrathyroidal fractions of exchangeable organic iodine pool At the time of peak uptake of the administered radioiodide by the thyroid only negligible amounts of organically bound iodine have been released from the thyroid. The fall in thyroidal radioactivity (fraction 131) from peak uptake to the asymptotic value then represents the portion of organic iodine in extrathyroidal tissues and the asymptotic value itself is the portion remaining in the thyroid at distribution equilibrium.
Calculation-In R. D. (Figure 3a) The rate of equilibration is found from the slope of the line joining the points of differences between the curve and the asymptotic value. X as given in the figure is equal to )Xz thyroid than in euthyroid subjects and averaged about 570 micrograms (range, 400 to 750 micrograms) in the latter group.
The thyroidal pool alone may be evaluated after distribution equilibrium has been attained without knowledge of the Il31 retained, since thyroidal and plasma specific activities are then essentially the same' and thyroidal and plasma radioactivity and plasma PBI27 are measurable. ' Theoretically the specific activities are never identical except at a single point (7), since excretion occurs solely from the extrathyroidal pool. However, since the rate of excretion of the total exchangeable pool is only about 1l per cent per day as compared to half times of 1 to 3 days for equilibrium between thyroidal and extrathyroidal pools, the specific activities are virtually identical after the plasma peak is reached.
This determination suffers from uncertainty as to the time of distribution equilibrium, in the absence of data on I'$' retained. However, equilibrium of distribution may be presumed when thyroidal and plasma curves show a parallel decline.
C. The extrathyroidal space of distribution of organic iodine 1. Estimations utilizing endogenously synthesized organic iodine Of the PBI"1l which is retained in the body, that which is not in the thyroid is distributed in the extrathyroidal tissues. Therefore, the apparent volume of distribution may be calculated from The extrathyroidal space of distribution of endogenously synthesized organic iodine ranged between 6 and 12 liters (11 to 22 per cent of body weight) with no evident significant differences between euthyroid and hyperthyroid subjects (Table I Figure 6 shows the plasma concentration curves for about 10 days following the injections. The terminal exponential decreases in concentration are presumably due to degradation and excretion of undegraded hormone, while the earlier portions of the curves represent the simultaneous processes of degradation and mixing in the extrathyroidal compartment. Although there is a continued increase in the space of distribution over a period of about 48 hours, the major fraction is distributed within 4 to 6 hours. In each case, the approximate volume of distribution of exogenous organic iodine was calculated from the total administered radioactivity divided by the PBI131 concentration at the zero time extrapolation of the terminal straight line portion of the curve (Figure 6 ).
The volumes in the three cases ranged from 8.7 to 11.7 liters (10.3 to 20.6 per cent body weight) which agree reasonably with the values obtained for endogenous organic iodine.
PART II-THYROIDAL SECRETION OF ORGANIC IODINE
A. Estimation of secretion rate from the kinetics of distribution of organic iodine between thyroidal and extrathyroidal pools Assuming that steady state conditions obtain during the course of the experiment, analysis of (Figures 3a, 4) and it may be recalled that mixing within the extrathyroidal pool ( Figure 6 ) is quite rapid compared to distribution between thyroidal and extrathyroidal pools (Figure 4) . B. Estimation of secretion rate from the decrease in thyroidal radioactivity during; tapazole inhibition
If the thyroid is prevented from reaccumulating radioiodide released by degradation of extrathyroidal organically bound iodine, the observed rate of decrease in thyroidal radioactivity should be a measure of thyroidal secretion. Therefore, during the administration of tapazole, thyroidal secretion of organic iodine was calculated as the product of the percentage rate of fall in thyroidal radioactivity and the thyroidal organic iodine pool.
Calculation-In R. D. (Figure 7 ) the thyroid lost 8.5 per cent per day of its initial activity for the first five days of tapazole therapy.
Since the thyroid contained 8,450 micrograms of organic iodine at the onset of treatment, as calculated above, the rate of thyroidal secretion = 8.5 per cent per day X 8,450 micrograms = 720 micrograms per day. Thyroidal secretion remained fairly constant for the first five to seven days of tapazole therapy but usually decreased thereafter in subjects with high rates of secretion ( Figure 7 , and J. St. in Figure 5 ). Values derived from the initial rates of secretion showed a range of 77 to 125 micrograms per day in euthyroid subjects and 450 to 925 micrograms per day in untreated hyperthyroid subjects (Table I ).
The validity of these determinations is based on the assumption that the drug acts only to block thyroidal binding of iodine and has no direct effect on the rate of thyroidal secretion. The reasonable agreement between the values for thyroidal secretion obtained by this method and those calculated from the kinetics of distribution suggests that tapazole neither increases nor decreases the rate of secretion, at least initially. Further speculations regarding possible effects of tapazole on thyroid secretion are deferred to the Discussion.
An additional concern was whether an increase in the thyroidal iodide pool during tapazole administration was likely to introduce any error into the measurements of thyroidal organic I'll and, therefore, into the calculations for thyroidal secretion. However ance of metabolized plasma organic iodine (after the initially administered iodide1"1 has disappeared from the circulation). This clearance has been termed "the apparent renal plasma organic iodine clearance" and is calculated from the daily (24-hour) urinary excretions of I131 divided by the mean plasma concentration of PBI11 over the 24-hour periods. The clearance rate is expressed as ml. plasma per day ( Figure   3b ), and is multiplied by the mean plasma PB11" concentration over the same period of time to give the rate of metabolic degradation of organic iodineln during tapazole administration.
CaJculation-In R. D. (Figure 3b) The values for the rate of organic iodine degradation calculated by this method are given under the column headed Method A in Table I . In euthyroid subjects the rates ranged from 67 micrograms to 108 micrograms per day.
In addition to the determinations made immediately after the institution of tapazole therapy, such measurements were also obtained at intervals during the course of therapy, as the plasma PBI concentrations decreased, in a number of the hyperthyroid subjects.
Calculation-In R. D. (Figure 3b) Figure 8 . The degradation rates in hyperthyroid patients brought to normal PBI levels did not differ significantly from the values obtained in euthyroid subjects. In all hyperthyroid patients followed in this manner the "clearance" rates decreased strikingly as the plasma PBI127 concentrations fell (Figure 3b ). (Table I) .
Calculation-In R. D. (Figure 3b) tapazole. The implication, therefore, is that in the unblocked state of the gland in these subjects, some fraction of the urinary iodine was organically bound and not subject to thyroidal accumulation. In these cases the calculated plasma iodide levels prior to tapazole administration were the lowest among the patients studied (see Part IV). Thus, a relatively high proportion of organic I'3l in the urine may be partly related to a high PBI ratio being preiodide sented to the kidneys. Quantitative evaluation of iodide and non-iodide fractions of urinary I'll should permit reliable determinations of the organic iodine degradation rates by this method, in all cases, even in the absence of tapazole inhibition. During tapazole administration, most of the urinary I'll represented iodide previously being accumulated by the thyroid and estimates of the organic iodine degradation rate were then not affected significantly by the presence of small amounts of organic I'3l in the urine.
In order to minimize errors resulting from changing blood levels and the lag in urinary excretion, the plasma organic iodine clearance measurements were made after the specific activity of the plasma had reached its peak and was changing at a relatively slow rate., This procedure is also necessary to avoid including in the urinary excretions any iodide"3' remaining initially from the injected dose which had not been synthesized into an organically bound form by the thyroid; e.g., note the higher excretions over the first few days shown in Figure 3 . B. Estimation of the rate of degradation from the fraction 31' excreted in the urine and the total exchangeable organic iodine pool The daily organic iodine degradation is also given by the product of the fraction I'll excreted ' Since at average normal renal clearance rates, the half time for removal of iodide from the body by the kidneys is about nine hours (2) a brief calculation shows that under these conditions, following thyroid block, the quantity of radioactive iodine excreted in the urine is over 90 per cent on the second day and over 98 per cent thereafter of the amount undergoing degradation. This rapid equilibration between degradation and renal excretion has previously been demonstrated for the metabolism of I1"' labelled serum albumin (9) . In the absence of thyroid inhibition, as is the case prior to tapazole administration, equilibration is even more rapid.
in the urine daily during tapazole administration and the total exchangeable organic iodine pool, and may, likewise, be calculated from the urinary excretions prior to tapazole blockage and the thyroidal iodide accumulation. Since these derenal terminations can be shown to be mathematically identical to those described in the previous paragraphs, they are not analyzed here in further detail.
C. Rate of degradation of transfused exogenous biosynthesized organic iodine Since distribution of the labeled donor plasma iodine continued for a period of about 48 hours (Figure 6 ), the rate of degradation could be evaluated only from points taken subsequently. Unfortunately, collections of excreta were incomplete in these cases and so fecal excretion was estimated at 121 per cent of degradation (see below). If it is assumed that urinary excretion of undegraded organic iodine was negligible and that in each case the recipient's organic iodine was metabolized at the same rate as the donor's, then the daily degradation rates were 256 micrograms, 68 micrograms, and 13 micrograms in the hyperthyroid, euthyroid and hypothyroid subjects, respectively (Table II) .
Hamolsky, Freedberg, Kurland, and Wolsky (10) performed transfusion experiments similar to those presented here. However, these investigators followed the plasma curves for periods of only 23 to 70 hours and assumed that distribution was complete within 4 to 5 hours. In addition, no account was taken of fecal excretion of organic iodine. Their calculated degradation rates, therefore, are probably too high, and their spaces of distribution too low.
D. The rate of organic iodine degradation as a function of PBI concentration in the plasma When the amount of organic iodine degraded daily was plotted against the plasma PBI127 concentrations for all subjects, including the values obtained during periods of declining PBI concentrations under tapazole therapy (Figure 8) , it became clear that degradation increases more rapidly than the plasma PBI concentration. The rate of organic iodine degradation was found to be roughly proportional to the square of the Table I , were determined from the renal plasma organic iodine clearance rates during the course of tapazole administration as described in the text. concentration ( Figure 9) 
E. Fecal excretion of organic iodine
For the first two or three days following the intravenous administration of NaI"11, fecal excretion usually was negligible indicating that iodide is not excreted in the stool to any significant extent. Following the appearance of PBI"'1 in the plasma, the fecal excretion of organic iodine was calculated from the fecal organic iodine clearance rates.
Calculation-In R. D. (Figure 3b) I .
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Fecal excretion of organic iodine generally amounted to about 10 to 15 per cent of the quantity degraded (Table I) . However, there did not appear to be such a striking dependence of the fecal clearance rate on the plasma PBI concentrations as was observed with the degradation process. In hyperthyroid patients with decreasing PBI levels under the influence of tapazole therapy there was an occasional slight decrease in fecal clearance (Figure 3b ). Euthyroid subjects appeared to have somewhat lower fecal clearance rates than the hyperthyroid patients but the data do not permit any definite expression of this relationship. In most of the subjects the rate of fecal clearance ranged from about 200 to 450 ml. per day. These values may be rederived from Table I by dividing the fecal excretions by the respective plasma PBI concentrations. -THE RATE OF REPLACEMENT OF THE  ORGANIC IODINE POOL WITH NEWLY IN-GESTED IODINE; ENDOGENOUS AND  EXOGENOUS IODINE BALANCE A. Organic iodine replacement rate and thyroidal uptake of exogenous iodine In subjects who are in the steady state, synthesis of thyroid hormone from newly ingested food iodine (exogenous iodine) must replace that lost by excretion of previously synthesized organic iodine (endogenous iodine). Assuming steady state conditions, the organic iodine replacement rate may then be calculated as the sum of urinary and fecal excretions of endogenous iodine prior to tapazole administration divided by the total exchangeable organic iodine pool.
Calculation-In R. D. (Figure 3b) Values for thyroidal uptake of exogenous iodine and the rate of organic iodine replacement are given in Table III . As expected, the replacement rates were higher in subjects with small pools and lower in those with large pools.
Data are not given for subjects recently treated with tapazole since there is evidence to indicate that they may be in periods of positive iodine balance as a result of previous depletion of the thyroid glands.
Theoretically, the organic iodine replacement rate may be derived from the thyroidal and plasma radioactivity curves as follows. If thyroidal and extrathyroidal radioactivities are expressed as fractions of the administered dose of I131, the following equations obtain (Appendix), T = (T, -c)e-1t + cent
where T and E represent the fractions of the administered dose of I'll in the respective compartments at any time, t, following peak uptake, T, is the fraction of the administered dose in the thyroid at peak uptake and X2 closely approximates the rate of exchange of newly ingested iodine with the total exchangeable organic iodine pool (organic iodine replacement rate). This is the rate at which the total exchangeable iodine pool would initially decrease, if iodine intake were abruptly discontinued and is clearly distinguished from the total turnover of organic iodine within the body which may be defined as the rate of thyroidal iodide accumulation or organic iodine secretion divided by the total exchangeable organic iodine pool. These equations are not very useful from the practical standpoint since the rate of organic iodine replacement (Table III) , is usually too small (1 to 2 per cent per day) to permit accurate evaluation of this rate within the period of time limited by the rate of decay of the isotope. However, the equations do indicate that distribution in the extrathyroidal pool contributes significantly to the early biologic decay curve of thyroidal radioactivity. It is only after distribution equilibrium is attained (5 to 10 days in most of the cases presented here) that the loss from the thyroid parallels loss from the body and can be 
B. Estimation of iodine intake
From the values for thyroidal uptake of exogenous iodine as derived above, the renal excretions of exogenous iodine were calculated, utilizing the renal iodide accumulation ratios.
thyroidal When both ratios were available the mean value was utilized for these calculations. Since fecal excretion of iodide is negligible, the iodine intake is then given by the sum of exogenous iodine accumulated by the thyroid and that excreted in the urine. In order to complete the balance sheet, thyroid uptake of endogenous iodine (Table III) is calculated from the increase in renal excretion of radioiodine following tapazole administration or from the renal excretion and the thyroidal iodide accumulation ratio in cases renal where tapazole was not administered.
C. Estimation of mean plasma iodide concentrations Since daily thyroidal accumulation (endogenous plus exogenous iodine) is equal to the product of the daily thyroidal clearance of iodide and the mean plasma iodide concentration, the latter could be calculated from the other data available. The calculated plasma iodide concentrations ranged from 0.1 to 0.5 microgram per liter plasma in all but two subjects for whom sufficient data were available (Table III) to the 48-hour point is not uncommon. An example of the opposite situation is presented by S. K., a hyperthyroid subject with a thyroidal pool of almost 20,000 micrograms iodine who showed a peak concentration in the plasma of only 0.15 per cent of the administered dose per liter and less than 0.1 per cent on the third day. It is clear that the diagnosis of relapse of hyperthyroidism after therapy of Graves' disease should not be influenced by high plasma PBI '3' concentrations and also that occasional cases of hyperthyroidism with large thyroidal iodine pools may fail to show high PBI'3' concentrations in the plasma.
Effect oJ tapazole on thyroid secretion
The nature of the factors controlling iodine release from the thyroid during tapazole administration is not clear. For the first few days, release did not appear to be affected as judged by comparison with the values obtained from the distribution curves prior to tapazole blockage, and those determined for the sum of peripheral degradation and fecal excretion at the same time. In hyperthyroid subjects, thyroidal secretion is definitely retarded after several days of tapazole therapy but this may be related to the decrease in the organic iodine content of the thyroid rather than to a specific effect of tapazole. In view of the falling plasma PBI levels, the decrease in the rate of release of thyroidal iodine is unlikely to be due to diminished pituitary secretion of TSH. Perhaps the thyroid itself is sensitive to changes in its hormonal iodine content and acts to prevent a rapid depletion of iodine stores. An alternative possibility is that an increase in the thyroidal iodide pool, resulting from inhibition of binding, may directly or indirectly effect a decrease in the rate of release of organic iodine by the thyroid. This would be consistent with the effect of iodine administration which also retards release of hormone and yet increases both the organic iodine and iodide contents of the thyroid, at least temporarily. 
